Walking Green: The Effects of Walking in Forested and Urban Areas

Obesity Clinical Trial

— NUWG  

Official title:

Walking Green: The Effects of Walking in Forested and Urban Areas on Health and Well-being

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03950661
• Other study ID #: STU00201604
• Status: Completed
• Phase: N/A
• Start date: June 1, 2016
• Est. completion date: December 8, 2017

Study information

• Verified date: May 2023
• Source: Northwestern University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This research hypothesizes that moderate physical activity in a "green environment" (e.g. a forest preserve path) has increased benefits on psychological measures (stress, anxiety, mood, depression, attention) and on physiological measures (Heart Rate Variability, Blood Glucose, Salivary Cortisol) when directly compared to activity in a "gray environment" (urban or suburban sidewalks).

The study design is a randomized crossover design in which each subject is assigned randomly to a group which determines the order in which participants will walk in each location. Subjects will take three 50-minute walks per location in one week, with half of the subjects taking the urban walks first as per group assignment. Control data are collected on days when participants do not walk. Physiological data are taken during walks and control periods (heart rate, heart rate variation). Biomarker samples (saliva, dried blood spots) are taken on selected days. Psychological data are take before and after walks and control periods.

Description:

This study records the psychological and physiological effects of green vs gray walks during a longitudinal crossover study on 41 participants. In accordance with the Attention Restoration and Stress Recovery theories we hypothesize that exposure to a green environment will have beneficial health outcomes for participants both psychologically (mood, stress, anxiety, depression, attention) and physiologically (blood glucose, heart rate variability, cortisol).

Participants will be randomly assigned to a study group which determines the order in which they will walk in either the gray or green location. The study takes place for 29 days of which only 9 are active study dates. The cross-over design controls for training effects that may result from the regular physical activity. Participants provided informed consent on Day

1. Walks will be monitored on Days 8, 12, 22, 26, while walks on days 10 and 24 have no monitoring to reduce testing burden. Days 15 and 29 are control days in which the participants are monitored during the day (Activities of Daily Living) as a control against the location they had previously walked in. No walks will be taken between days 12 and 21 to provide a washout period from the previous location. Psychological tests are administered by computer using the Qualtrics software platform to assess:

Positive and Negative Affect Scale (PANAS) Center for Epidemiological Studies Depression Scale (CESD) State and Trait Anxiety Inventory (STAI) Cohen's Perceived Stress Scale (UCLA) Perceived Isolation Scale Nature Relatedness Scale (NR-6)

Anthropometric measures are taken on days 1, 8, 15, 22, and 29. Physiological effects are studied through heart rate monitoring during all monitored walks via a Zephyr Omnisense which records heart information as well as activity, temperature and breathing rate. Salivary cortisol is collected on days 7, 14, 21, and 28 by the participant. Blood glucose is measured on days 8, 12, 15, 22, 26, and 29; dried blood spots are collected for future analysis of inflammatory biomarkers.

Hypotheses will be tested using fixed and random effects linear regression models using the appropriate statistical procedures in SAS 9.4 to test for main effects, covariates, and other confounding variables that were measured throughout the study including individuals' reported stress and tiredness, and the weather conditions of the day.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 82
• Est. completion date: December 8, 2017
• Est. primary completion date: August 14, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• over the age of 18

• under the age of 35

• no current infections / recent infections (<2weeks)

• PAR-Q+ scores indicative of readiness to engage in physical activity

Exclusion Criteria:

• Women who are pregnant or breast-feeding

• Inability to consent

• Incarcerated Persons

• non-adults

Related Conditions & MeSH terms

• Anxiety
• Depression
• Health Behavior
• Mood
• Obesity
• Physical Activity
• Stress

Intervention

Other:
• Walking

Locations

Country	Name	City	State
United States	Northwestern University	Evanston	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
Northwestern University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Psychological Effects - Mood	Change in Positive and Negative Affect scale 0 = never, 4 = very often. Higher Positive Affect scores reflect better reported mood scores. Lower Negative Affect Scores reflect better mood scores. Average values based on age	29 days
Primary	Psychological Effects - Anxiety	change in STAI (STAI-TRAIT anxiety) score based on a Likert scale self reported score. Higher scores indicate a higher level of self-reported anxiety.	29 days
Primary	Psychological Effects - Attention	change in vBDS (backward digit span) score lower scores indicate a increased inability to properly recall the numbers in the test.	29 days
Primary	Psychological Effects - Depression	change in CESD score. Possible range of scores is 0 to 60, with the higher scores indicating the presence of more symptomatology. Citation: Radloff LS: The CES-D Scale: a self-report depression scale for research in the general population.	29 days
Secondary	Physiological Effects - Blood Glucose	Glucose levels as markers of health and wellness. (mg/dL)	29 days
Secondary	Physiological Effects - Salivary Cortisol	Diurnal cortisol dynamics measured by salivary cortisol (ug/dl), as the normal drop in cortisol during the day is attenuated by exposure to chronic stress.	29 days
Secondary	Physiological Effects - Blood	Pro- and anti-inflammatory cytokine concentrations in blood (pg/mL), as stress typically induces an inflammatory response	29 days
Secondary	Physiological Effects - Heart Rate Variation	changes in HRV is indicative of parasympathetic input (milliseconds), higher HRV correlating to reduced stress.	29 days